A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

NCT03204032 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Extrapancreatic Neuroendocrine Tumor

Interventions

DRUG: Tegafur
DRUG: Temozolomide
DRUG: Thalidomide

Sponsor

Chinese Academy of Medical Sciences